MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

MDT

89.97

+0.71%↑

VEEV

275.84

-1.9%↓

A

123.3

-0.67%↓

WBA

11.51

-0.35%↓

HQY

94.45

-2.78%↓

Search

Codexis Inc

Închisă

SectorSănătate

2.99 -4.17

Rezumat

Modificarea prețului

24h

Curent

Minim

2.96

Maxim

3.12

Indicatori cheie

By Trading Economics

Venit

-10M

-21M

Vânzări

-14M

7.5M

Marjă de profit

-274.268

Angajați

188

EBITDA

-11M

-20M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+78.69% upside

Dividende

By Dow Jones

Următoarele câștiguri

7 aug. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

11M

229M

Deschiderea anterioară

7.16

Închiderea anterioară

2.99

Sentimentul știrilor

By Acuity

35%

65%

122 / 376 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Codexis Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

10 iul. 2025, 21:42 UTC

Achiziții, Fuziuni, Preluări

Justice Department Won't Seek Injunction for T-Mobile Acquisition of U.S. Cellular

10 iul. 2025, 17:06 UTC

Achiziții, Fuziuni, Preluări

Portugal Begins Process to Sell Stake in National Carrier -- Update

10 iul. 2025, 17:00 UTC

Principalele dinamici ale pieței

K Wave Media Shares Drop After Convertible Note Agreement With Anson Funds

10 iul. 2025, 16:31 UTC

Achiziții, Fuziuni, Preluări

Blackstone Makes $664 Million Counteroffer for Warehouse REIT Amid Bidding War -- 2nd Update

10 iul. 2025, 23:47 UTC

Market Talk

Gold Edges Higher Amid Lingering Global Trade Tensions -- Market Talk

10 iul. 2025, 23:40 UTC

Market Talk

Nikkei May Trade Rangebound Amid U.S. Tariff Uncertainty -- Market Talk

10 iul. 2025, 22:36 UTC

Market Talk

Tourism Holdings' Profit Warning Less Concerning Than Others -- Market Talk

10 iul. 2025, 22:23 UTC

Market Talk

New Law Creates Winners and Losers Among Renewable-Energy Projects -- Market Talk

10 iul. 2025, 20:50 UTC

Market Talk
Câștiguri

Auto & Transport Roundup: Market Talk

10 iul. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 iul. 2025, 20:00 UTC

Achiziții, Fuziuni, Preluări

Toyota Tsusho America Completes Acquisition of Radius Recycling

10 iul. 2025, 19:56 UTC

Market Talk

Gold Rises on Inflation Concerns -- Market Talk

10 iul. 2025, 19:33 UTC

Market Talk

Oil Snaps Winning Streak As Oversupply Concerns Return -- Market Talk

10 iul. 2025, 19:21 UTC

Market Talk

U.S. Natural Gas Rebound on Benign Storage Build -- Market Talk

10 iul. 2025, 18:46 UTC

Market Talk

Mexican Industrial Production Seen as Mixed in May -- Market Talk

10 iul. 2025, 18:15 UTC

Market Talk

Brazil's Bullish Outlook Expected to Survive Trump Tariffs -- Market Talk

10 iul. 2025, 18:03 UTC

Market Talk
Câștiguri

Travel Agency Investors Cautiously Optimistic After Delta Report -- Market Talk

10 iul. 2025, 17:57 UTC

Market Talk

US Labor Shortage Could Weigh on Business, Economic Growth -- Market Talk

10 iul. 2025, 17:34 UTC

Câștiguri
Achiziții, Fuziuni, Preluări

Conagra Falls While Simply Good Foods Adapts. What's Eating Food Companies. -- Barrons.com

10 iul. 2025, 17:34 UTC

Market Talk

Canada Vows Fight Over Trump's Copper Tariffs -- Market Talk

10 iul. 2025, 17:20 UTC

Market Talk

Copper Climbs as Futures Wrangle With Trump Tariff -- Market Talk

10 iul. 2025, 17:20 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

10 iul. 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

10 iul. 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

10 iul. 2025, 16:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10 iul. 2025, 16:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10 iul. 2025, 16:02 UTC

Market Talk

Global Equities Roundup: Market Talk

10 iul. 2025, 16:02 UTC

Market Talk

Embraer Expected to Bear Brunt of U.S. Tariffs on Brazil -- Market Talk

10 iul. 2025, 16:01 UTC

Achiziții, Fuziuni, Preluări

Investor AB: Advanced Instruments' Acquisition of Nova Biomedical Completed

10 iul. 2025, 15:41 UTC

Market Talk

U.S. Natural Gas Storage Surplus Holds Steady -- Market Talk

Comparație

Modificare preț

Codexis Inc Așteptări

Obiectiv de preț

By TipRanks

78.69% sus

Prognoză pe 12 luni

Medie 5.2 USD  78.69%

Maxim 11 USD

Minim 2.5 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCodexis Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

6 ratings

4

Cumpărare

2

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

2.25 / 2.53Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Strong Bearish Evidence

Termen lung

Bearish Evidence

Sentiment

By Acuity

122 / 376 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, the company is currently developing its proprietary ECO Synthesis(tm) manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.